Free Trial

SVB Wealth LLC Purchases Shares of 4,992 Henry Schein, Inc. (NASDAQ:HSIC)

Henry Schein logo with Medical background
Remove Ads

SVB Wealth LLC purchased a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 4,992 shares of the company's stock, valued at approximately $345,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. FMR LLC lifted its holdings in Henry Schein by 7.8% in the 3rd quarter. FMR LLC now owns 3,280,890 shares of the company's stock worth $239,177,000 after purchasing an additional 237,888 shares during the last quarter. Southpoint Capital Advisors LP lifted its holdings in Henry Schein by 30.0% in the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company's stock worth $189,540,000 after purchasing an additional 600,000 shares during the last quarter. Nuance Investments LLC lifted its holdings in Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock worth $166,072,000 after purchasing an additional 414,748 shares during the last quarter. Clarkston Capital Partners LLC lifted its holdings in Henry Schein by 5.4% in the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company's stock worth $101,900,000 after purchasing an additional 71,560 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Henry Schein by 0.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company's stock worth $85,662,000 after purchasing an additional 6,184 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on HSIC shares. Jefferies Financial Group boosted their target price on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Wells Fargo & Company began coverage on Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target for the company. Barrington Research reiterated an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a report on Wednesday, February 26th. UBS Group cut their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Finally, Mizuho began coverage on Henry Schein in a report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price target for the company. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Henry Schein presently has a consensus rating of "Moderate Buy" and a consensus target price of $81.10.

Read Our Latest Report on HSIC

Henry Schein Stock Performance

Shares of HSIC traded up $1.63 on Friday, reaching $74.59. 2,145,365 shares of the stock traded hands, compared to its average volume of 1,487,644. The firm has a market cap of $9.26 billion, a price-to-earnings ratio of 30.70, a P/E/G ratio of 2.13 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.49. The stock's 50-day moving average price is $74.48 and its 200-day moving average price is $72.51.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.66 earnings per share. Equities analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads